Not long after the FDA wrapped its preliminary investigation of GLP-1 receptor agonists and suicidal thoughts or actions, the ...

GLP-1, or Glucagon-like peptide-1, medications, similar to Ozemppic and Wegovy, are becoming more accessible, and while the ...

A study suggests that GLP-1 agonist drugs, like Ozempic, may reduce overdose risks and aid in addiction treatment. Further ...

This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...

Musk has been an advocate for the widespread use of GLP-1 inhibitors to combat obesity. His stance has sparked debates, such ...

Alzheimer's, addiction, cardiovascular diseases, kidney disorders, sleep apnoea, diabetes, obesity, and overweight.

Mounjaro, which has been dubbed the "King Kong" of weight-loss drugs, is considered more effective than its competitors with ...

Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

Two SciFri producers discuss the year’s most intriguing stories, from new weight-loss drugs to PFAS chemicals to the ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...